Storia in 2 fonti

UAE first country in world to approve new oral breast cancer drug for hormone-resistant cases

Etcamah oral therapy for ESR1 mutations offers hope for patients when hormone therapy stops working, causes gene mutation

Raccontata da

gulfnews.com

thenationalnews.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

gulfnews.comStai leggendo7 g fa

UAE first country in world to approve new oral breast cancer drug for hormone-resistant cases

Etcamah oral therapy for ESR1 mutations offers hope for patients when hormone therapy stops working, causes gene mutation

originale

thenationalnews.com7 g fa

UAE approves breast cancer drug aimed at stopping tumours from growing | The National

AstraZeneca's Etcamah received UAE approval for advanced breast cancer, reducing death risk by 56% and extending time before chemotherapy from 9 to 16 months. The approval—ahead of FDA rejection—signals UAE's regulatory agility emerging as a faster pathway for pharmaceutical innovation, reshaping enterprise healthcare investment decisions.

Timeline cronologica

giovedì 11 giugno 2026·gulfnews.com
UAE first country in world to approve new oral breast cancer drug for hormone-resistant cases
Etcamah oral therapy for ESR1 mutations offers hope for patients when hormone therapy stops working, causes gene mutation
giovedì 11 giugno 2026·thenationalnews.com
UAE approves breast cancer drug aimed at stopping tumours from growing | The National
Emirates Drug Establishment is among the first regulators globally to approve Etcamah